Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The search for new beta-cell sources.

Gorka Orive1, Alicia R Gascón, Rosa M Hernández

  • 1Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, Vitoria-Gasteiz, 01002, Spain.

Trends in Biotechnology
|November 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ready-to-use 3D bioprinted scaffolds from natural materials loaded with patient's PRGF for personalized skin regeneration.

iScience·2026
Same author

Engineering early immune resilience in islet transplantation.

Trends in pharmacological sciences·2026
Same author

State-of-the-Art and Next Generation Intra-Articular Implantable Biosensors for Osteoarthritis: From Analytical Limits to Operational Stability.

Biosensors·2026
Same author

Tracing illicit and prescription drug use in a Spanish prison by combining wastewater analysis and pharmaceutical dispensing data.

Environmental toxicology and pharmacology·2026
Same author

Recent advances in the use of gelatin as a biomaterial for tissue engineering.

International journal of pharmaceutics·2026
Same author

Engineering chitosan-functionalized liposomes for targeted drug delivery and biomedical applications.

International journal of biological macromolecules·2026

Type 1 diabetes, an autoimmune disease, impacts millions globally by destroying insulin-producing beta-cells. Researchers are developing new therapies for improved glycemic control in affected individuals.

Area of Science:

  • Immunology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 1 diabetes is an autoimmune condition characterized by the destruction of insulin-producing beta-cells.
  • The disease affects approximately 150 million people worldwide, with over 16 million in the United States.
  • Diabetes management represents a significant financial burden, accounting for a substantial portion of healthcare expenditures.

Purpose of the Study:

  • To explore novel therapeutic strategies for Type 1 diabetes.
  • To achieve optimal glycemic control in patients with diabetes.
  • To address the significant healthcare costs associated with diabetes management.

Main Methods:

  • Investigating autoimmune mechanisms underlying beta-cell destruction.
  • Developing innovative treatment approaches for diabetes.

Related Experiment Videos

  • Evaluating methods for precise blood glucose regulation.

    • Main Results:

    • Identification of promising therapeutic targets for Type 1 diabetes.
    • Demonstration of potential for enhanced glycemic control.
    • Insights into cost-effective diabetes management.

    Conclusions:

    • Novel therapeutic strategies show promise for managing Type 1 diabetes.
    • Improved glycemic control is achievable for a majority of patients.
    • Continued research is crucial for addressing the global impact of diabetes.